Related Experiment Video
Updated: Jun 20, 2026

Assessing Functional Performance in the Mdx Mouse Model
Published on: March 27, 2014
MDM4 (MDMX) and its Transcript Variants
F Mancini1, G Di Conza, F Moretti
1National Council of Research, Institute of Neurobiology and Molecular Medicine, Roma.
Abstract:
MDM family proteins are crucial regulators of the oncosuppressor p53. Alterations of their gene status, mainly amplification events, have been frequently observed in human tumors.MDM4 is one of the two members of the MDM family. The human gene is located on chromosome 1 at q32-33 and codes for a protein of 490aa. In analogy to MDM2, besides the full-length mRNA several transcript variants of MDM4 have been identified. Almost all variants thus far described derive from a splicing process, both through canonical and aberrant splicing events. Some of these variants are expressed in normal tissues, others have been observed only in tumor samples. The presence of these variants may be considered a fine tuning of the function of the full-length protein, especially in normal cells. In tumor cells, some variants show oncogenic properties.This review summarizes all the different MDM4 splicing forms thus far described and their role in the regulation of the wild type protein function in normal and tumor cells. In addition, a description of the full-length protein structure with all known interacting proteins thus far identified and a comparison of the MDM4 variant structure with that of full-length protein are presented. Finally, a parallel between MDM4 and MDM2 variants is discussed.
Insights
MDM4 (MDM family member 4) splicing variants fine-tune wild-type protein function in normal cells but can promote oncogenesis in tumors. This review details MDM4 variants, their structures, and interactions, comparing them to MDM2 variants.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- MDM family proteins regulate the oncosuppressor p53, with gene alterations frequently observed in human tumors.
- MDM4, a member of the MDM family, is encoded by a gene on chromosome 1 and exists as a full-length protein and various transcript variants.
- These MDM4 variants arise from canonical and aberrant splicing, with some found in normal tissues and others exclusively in tumors.
Purpose of the Study:
- To review all described MDM4 splicing forms and their regulatory roles on wild-type MDM4 function in both normal and tumor cells.
- To present the structure of full-length MDM4 protein, its interacting partners, and compare the structures of MDM4 variants to the full-length protein.
- To discuss the parallels between MDM4 and MDM2 variants in cancer biology.
Main Methods:
- Literature review of studies describing MDM4 splicing variants.
- Analysis of protein structure and interactions of full-length MDM4.
- Comparative analysis of MDM4 and MDM2 variants.
Main Results:
- MDM4 variants are generated through splicing, including aberrant events, and exhibit differential expression in normal versus tumor tissues.
- Some MDM4 variants modulate the function of the full-length protein in normal cells, while others possess oncogenic properties in tumor cells.
- The review provides a comprehensive overview of MDM4 variant structures, interactions, and functional implications.
Conclusions:
- MDM4 splicing variants play a significant role in regulating p53 pathway activity, impacting both normal cellular functions and tumor development.
- Understanding MDM4 variants is crucial for comprehending cancer mechanisms and potentially developing targeted therapies.
- The comparison with MDM2 variants highlights conserved and distinct roles of MDM family members in cancer.
Related Concept Videos
Master Transcription Regulators
Master Transcription Regulators
Abnormal Proliferation
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...

